- List
- By Topic
- On Map
- Search Details

"RWJMS" OR "Robert Wood Johnson Medical School" OR "Cancer Institute of New Jersey" OR "CINJ" | Recruiting, Not yet recruiting, Available Studies | "Esophageal Diseases"
Need help? See RSS Feeds
Choose a feed type:

"RWJMS" OR "Robert Wood Johnson Medical School" OR "Cancer Institute of New Jersey" OR "CINJ" | Recruiting, Not yet recruiting, Available Studies | "Esophageal Diseases" (2 records)
Need help? See Downloading Content for Analysis
For Advanced Users: Full Study Record XML Download
1 | NCT02465060 | Recruiting | Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) |
|
|
Interventional | Phase 2 |
|
NIH |
|
|
6452 | All | 18 Years and older (Adult, Senior) | NCT02465060 | NCI-2015-00054 EAY131 U10CA180820 U24CA196172 |
August 12, 2015 | June 30, 2022 | June 8, 2015 | April 17, 2018 |
|
|||
2 | NCT01366144 | Recruiting | Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction |
|
|
Interventional | Phase 1 |
|
NIH / Industry |
|
|
276 | All | 18 Years and older (Adult, Senior) | NCT01366144 | NCI-2011-02500 UPCI 10-115 CDR0000700997 UPCI-10-115 8808 N01CM00100 P30CA047904 U01CA062490 U01CA062502 U01CA062505 U01CA069856 U01CA070095 U01CA099168 UM1CA186690 UM1CA186691 UM1CA186709 UM1CA186717 |
June 20, 2011 | July 31, 2017 | June 3, 2011 | July 26, 2017 |
|
† Study has passed its completion date and status has not been verified in more than two years.